Zambon Biotech S.A.

2 trials 1 recruiting Commercial sponsor Merged from 2 name variants

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

8 Countries active

3 Unique IMPs

100% Results reported

Phase III

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Parkinson's disease 1

Top IMPs

CICLOSPORIN A 1 LEVODOPA, CARBIDOPA MONOHYDRATE 1

All trials

2 total

A Phase 3b open-label, randomised study of IPX203 in subjects with advanced Parkinson’s disease and motor fluctuations - ADIP study Recruiting

2025-521772-57-00 Phase III 3 countries LEVODOPA, CARBIDOPA MONOHYDRATE
Clinical research study to investigate efficacy and safety of Liposomal Cyclosporine A (L-CsA) in patients with Bronchiolitis Obliterans Syn… Ended

2024-512448-41-00 Phase III 6 countries CICLOSPORIN A

Showing 1–2 of 2 trials

← All sponsors A–Z